These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23304031)

  • 1. Current and future options for treating esophageal cancer: a paradigm shift toward organ-sparing therapies.
    Hofstetter W
    Tex Heart Inst J; 2012; 39(6):846-7. PubMed ID: 23304031
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current surgical treatment and perspectives for esophageal cancer].
    Tsubosa Y
    Nihon Shokakibyo Gakkai Zasshi; 2014 Feb; 111(2):269-75. PubMed ID: 24500316
    [No Abstract]   [Full Text] [Related]  

  • 3. Salvage esophagectomy after definitive chemotherapy and radiotherapy for advanced esophageal cancer.
    Nakamura T; Hayashi K; Ota M; Eguchi R; Ide H; Takasaki K; Mitsuhashi N
    Am J Surg; 2004 Sep; 188(3):261-6. PubMed ID: 15450831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Esophageal surgery].
    Vereczkei A
    Magy Seb; 2012 Jun; 65(3):98-107. PubMed ID: 22717964
    [No Abstract]   [Full Text] [Related]  

  • 5. [Salvage surgery in esophageal cancer : Feasibility in patients after definitive radiochemotherapy (> 50 Gy)].
    Schmidt T; Sisic L; Sterzing F; Haag GM; Kunzmann R; Grenacher L; Weichert W; Jäger D; Büchler MW; Ott K
    Chirurg; 2015 Oct; 86(10):955-62. PubMed ID: 25715974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma.
    Ni W; Yu S; Zhang W; Xiao Z; Zhou Z; Chen D; Feng Q; Liang J; Lv J; Gao S; Mao Y; Xue Q; Sun K; Liu X; Fang D; Li J; Wang D
    BMC Cancer; 2020 Feb; 20(1):130. PubMed ID: 32070309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal preoperative neoadjuvant therapy for resectable locally advanced esophageal squamous cell carcinoma.
    Leng XF; Daiko H; Han YT; Mao YS
    Ann N Y Acad Sci; 2020 Dec; 1482(1):213-224. PubMed ID: 33067818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolated local recurrence or solitary solid organ metastasis after esophagectomy for cancer is not the end of the road.
    Depypere L; Lerut T; Moons J; Coosemans W; Decker G; Van Veer H; De Leyn P; Nafteux P
    Dis Esophagus; 2017 Jan; 30(1):1-8. PubMed ID: 27704661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
    Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
    Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mediastinoscopic salvage esophagectomy for recurrent esophageal squamous cell carcinoma after definitive chemoradiotherapy in a previously pneumonectomized patient.
    Okumura T; Seto Y; Aikou S; Moriyama M; Sekine S; Hashimoto I; Shibuya K; Hojo S; Yoshioka I; Nagata T; Fujii T
    Asian J Endosc Surg; 2019 Oct; 12(4):452-456. PubMed ID: 30411514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Patterns of recurrence in patients with stage Ⅲ thoracic esophageal squamous cell carcinoma after radical resection].
    Wang YX; Yang Q; He M; Qiu R; Li J; Zhu SC; Qiao XY; Qi Z
    Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):48-55. PubMed ID: 28104034
    [No Abstract]   [Full Text] [Related]  

  • 12. [Combined modality treatment of oesophageal cancer].
    Stahl M; Ruhstaller T
    Internist (Berl); 2014 Jan; 55(1):7-8, 10-4. PubMed ID: 24154497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Management of esophageal squamous cell carcinoma and adenocarcinoma: surgical, endoscopic, and radiotherapeutic options].
    González Tallón AI; Rodríguez Gandía MÁ; Fernández Lizarbe E
    Med Clin (Barc); 2012 Dec; 139(13):588-92. PubMed ID: 22841469
    [No Abstract]   [Full Text] [Related]  

  • 14. Morbidity following salvage esophagectomy for squamous cell carcinoma: the MD Anderson experience.
    Mitchell KG; Nelson DB; Corsini EM; Vaporciyan AA; Antonoff MB; Mehran RJ; Rice DC; Roth JA; Sepesi B; Walsh GL; Bhutani MS; Maru DM; Wu CC; Nguyen QN; Ajani JA; Swisher SG; Hofstetter WL
    Dis Esophagus; 2020 Mar; 33(3):. PubMed ID: 31313820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. REG I expression predicts long-term survival among locally advanced thoracic squamous cell esophageal cancer patients treated with neoadjuvant chemoradiotherapy followed by esophagectomy.
    Motoyama S; Sugiyama T; Ueno Y; Okamoto H; Takasawa S; Nanjo H; Watanabe H; Maruyama K; Okuyama M; Ogawa J
    Ann Surg Oncol; 2006 Dec; 13(12):1724-31. PubMed ID: 17009160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance Following Treatment of Esophageal Cancer.
    Bakhos CT; Acevedo E; Petrov RV; Abbas AE
    Surg Clin North Am; 2021 Jun; 101(3):499-509. PubMed ID: 34048769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stage-directed individualized therapy in esophageal cancer.
    Goense L; van Rossum PS; Kandioler D; Ruurda JP; Goh KL; Luyer MD; Krasna MJ; van Hillegersberg R
    Ann N Y Acad Sci; 2016 Oct; 1381(1):50-65. PubMed ID: 27384385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
    Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
    Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer.
    Urschel JD; Vasan H; Blewett CJ
    Am J Surg; 2002 Mar; 183(3):274-9. PubMed ID: 11943125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal Use of Combined Modality Therapy in the Treatment of Esophageal Cancer.
    Shaikh T; Meyer JE; Horwitz EM
    Surg Oncol Clin N Am; 2017 Jul; 26(3):405-429. PubMed ID: 28576180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.